Published on 09 Apr 2013
Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.
PDF (538.25 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
My experience with the review stages and manuscript processing in Cancer Growth and Metastasis has been of excellence. The fine balance of times utilized for proper scientific assessment of the material and quality control is greatly commended.